Search
InSilico Medicine Re-applies for Listing on Hong Kong Exchanges and Clearing Limited
2025-05-09 /
Read about 0 minute
Author：小编
InSilico Medicine, a pioneering AI-driven drug research and development company, has re-submitted its listing application to the Hong Kong Exchanges and Clearing Limited. The joint sponsors for this application are Morgan Stanley, China International Capital Corporation (CICC), and GF Securities (Hong Kong). As a globally renowned AI biotechnology firm, InSilico Medicine specializes in leveraging artificial intelligence for groundbreaking advancements in drug discovery and development.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
